Study on maternal and perinatal outcome in eclampsia in a tertiary care hospital
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20231932Keywords:
Disseminated intravascular coagulation, Feto-maternal outcome, Near miss, Mortality, Posterior reversible encephalopathy syndromeAbstract
Background: Eclampsia is an unpredictable multi-organ disease unique to pregnancy and is largely a preventable condition, responsible for high maternal and perinatal mortality.
Methods: The present study was conducted in the Department of Obstetrics and Gynaecology in Maharani Laxmi Bai Medical College, Jhansi. It was a retrospective study conducted over a period of 12 months on all eclamptic cases attending our hospital and feto-maternal outcome data was analysed.
Results: The incidence of eclampsia in our hospital was 2.22%. Most of the eclamptic cases were antepartum eclampsia constituting 81.48%. During the study period there were a total of 2430 obstetric admissions out of which 54 were eclamptic cases. There were 89 near miss cases and 21 maternal deaths. 16 (17.97%) near miss cases and 7(33.33%) maternal deaths were due to eclampsia. 37.03% patients had complications. Pulmonary edema/ARDS was the most common complication seen in our study. Early neonatal mortality in our study was 11.11%, 11 new-borns needed NICU care. Prematurity was the most common cause.
Conclusions: Adequate screening, monitoring and routine check-up during and after pregnancy may prevent worsening the maternal and foetal outcome. Lack of antenatal care is a common risk factor for eclampsia is and this needs to be addressed to prevent this serious complication of pregnancy.
Metrics
References
McDonald SD, Han Z, Walsh MW, Gerstein HC, Devereaux PJ. Kidney disease after preeclampsia: a systematic review and meta-analysis. Am J Kidney Dis. 2010;55(6):1026-39.
Duckitt K, Harrington D. Risk factors for preeclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;330(7491):565.
Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet. 2001;357(9249):53-6.
Page EW. The relation between hydatid moles, relative ischemia of the gravid uterus and the placental origin of eclampsia. Am J Obstet Gynecol. 1939;37(6):291-3.
Roberts JM. Preeclampsia: what we know and what we do not know. Semin Perinatol. 2000;24(1):24-8.
Pal B, Niyogi G, Patkar V. Maternal mortality in eclampsia. J Obstet Gynecol Ind. 1997;47:11-7.
Desai P. Changes in perinatal outcome due to magnesium sulphate in eclampsia. J Obstet Gynaecol India. 1995;45:732-5.
Sheraz S, Boota M. Shahzad S. Eclapsia. Prof Med J. 2006;13(1):27-31.
Sarma HK, Talukdar B. Eclampsia a clinical prospective study in a referral hospital J. Obstet Gynecol Barpeta. 2014;1(1):57-61.
Dutta MR, Pant L, Kabiraj M, Basu SB. Magnesium sulfate in eclampsia: A safe, efficient andcost-effective approach. J Obstet Gynecol India. 2002;52(3):65-8.
Shaheen B, Hassan L, Obaid M. Eclampsia, a major cause of maternal and perinatal mortality: A prospective analysis at tertiary care hospital of Peshawar. J Pak Med Assoc. 2003;53(8):346.
Nessa K, Khan S, Begum S, Sultana F, Akbar T. Incidence and Fetomaternal Outcome of Eclampsia in a Tertiary Medical College Hospital in Bangladesh. Glob J Med Res. 2017;17(2):1-4.
Raji C, Poovathi M, Nithya D. Prospective study of fetomaternal outcome in eclampsia in a tertiary care hospital. Int J Reprod Contracept Obstet Gynecol. 2016;5(12):
Ghimire S. Eclampsia: feto-maternal outcomes in a tertiary care centre in eastern Nepal. J Nepal Med Assoc. 2016;54(201).
Downloads
Published
How to Cite
Issue
Section
